COMPANY LED - IRINOTECAN 200MG/ 260ML IN SODIUM CHLORIDE 0.9% W/V INTRAVENOUS INFUSION AND INFLIXIMAB (REMSIMA) INTRAVENOUS INFUSION IN SODIUM CHLORIDE 0.9%

Qualasept Ltd t/a Bath ASU is recalling a specific batch of Irinotecan 200mg/260mL in sodium chloride 0.9% w/v intravenous infusion and specific batches of Infliximab (Remsima) Intravenous infusion in Sodium Chloride 0.9%w/v due to risks of reduced product quality

MHRA drug alert link https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-irinotecan-200mg-slash-260ml-in-sodium-chloride-0-dot-9-percent-w-slash-v-intravenous-infusion-and-infliximab-remsima-intravenous-infusion-in-sodium-chloride-0-dot-9-percent?utm_medium=email&utm_campaign=govuk-notifications&utm_source=46e56b1e-074c-4df7-b8da-04593bef0bdc&utm_content=immediately     

Please note that Alliance Healthcare do not stock and we are not accepting stock returns.

Company Contact for medical information enquiries

For medical information enquiries, please contact Maria Connolly:

Tel: 01225 811131

Maria.connolly@bathasu.com

Company Contact for stock enquiries

For stock information enquiries,

Tel: 01225 811131

customerservices@bathasu.com